Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other approaches.

Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel therapies.

Xybion Corporation is pleased to announce the acquisition of Autoscribe Informatics. This acquisition represents a significant strategic expansion in the Company’s Laboratory Information Management System (LIMS) business globally.

Eremid® Genomic Services Partners With Semaphore Solutions To Implement Cutting-Edge Labbit LIMS.

Member-led steering committees composed of global pharma and tech representatives will develop new project ideas to drive industry change.

TESTA Analytical announce new 21CFR Part 11 compliance software for use with its popular family of NanoBrook particle sizing and zeta potential instrumentation.

Assays focus on accelerating cancer research.

CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.

Novel computational model accurately predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.

Using high-speed, web-based communications protocols - DP5 Network rack decoding software from Ziath can be run from a laptop, desktop, phone, or any other network connected device.